News
Does Soaring Novavax Stock Have Enough Fuel to Climb Higher?
Shares of the struggling vaccine developer Novavax (NASDAQ: NVAX) bounded 98.7% higher on Friday, May 10. The market was responding to terrific news from Sanofi (NASDAQ: SNY), a global
3 High-Yield Dividend Stocks to Buy Hand Over Fist in May
Investors have enjoyed higher Treasury yields, serving up passive income over the past couple of years. However, there's still an abundance of quality dividend stocks that offer potential price
What Is the Dividend Payout for AbbVie Stock?
Many investors hold a stake in AbbVie (NYSE: ABBV) because it offers exposure to the healthcare sector. Industry-based diversification, however, isn't all the pharmaceutical outfit brings to the
How Viking Therapeutics Stock Could 30x
Viking Therapeutics (NASDAQ: VKTX) has been one of the few bright spots in the healthcare sector this year. The biotech's shares have stormed higher by almost 300% year to date on the back of its
Is Viking Therapeutics the Best Biotech Stock for You?
Viking Therapeutics (NASDAQ: VKTX) isn't a household name, but if its plans to commercialize a powerful anti-obesity medicine come to fruition, it may well become one. Though it has yet to
EQS-News: Sartorius collaborates with Sanofi to commercialize end-to-end platform for downstream process intensification
Nvidia Is Leading the Artificial Intelligence (AI) Charge, But These 2 Companies Are Rising Stars
AI chip leader Nvidia (NASDAQ: NVDA) will no doubt have very strong growth over the next year-plus. But while the chip designers like Nvidia and its would-be competitors garner a lot of headlines
Want $1,000 in Dividend Income? Here's How Much You'd Have to Invest in Pfizer Stock
Pfizer (NYSE: PFE) stock has struggled over the past year, losing around 28% of its value. Its dividend payout, meanwhile, has continued to rise again and again. This combination has pushed the
Almirall Delivers Strong Start of 2024 – Q1 Net Sales Growth of 6.6% Overall and 18% in the European Dermatology Business, Driven by Biologics and Solid Performance of Broad Product Portfolio
Almirall, S.A. (ALM) a global biopharmaceutical company based in Barcelona, today announced its financial results from the first quarter 2024. Almirall delivered strong sales growth in the first
EQS-News: Newron reports compelling additional data documenting the efficacy of evenamide in pivotal study 008A in poorly responding schizophrenia patients
Vertex Pharmaceuticals Is Racing Towards a New Blockbuster: Why the Stock Is a Smart Buy
There are several textbook arguments against monopolies. According to one of them, companies that control a market can lower the quality of their products with impunity.
However, Vertex
Billionaire Jim Simons Owns These 2 Healthcare Stocks: Should You?
Many billionaire investors are going all in on artificial intelligence (AI). That's understandable. AI is quickly being integrated into businesses' day-to-day operations. The leaders in the field
2 Unbelievable Growth Stocks You Can Buy and Hold for the Next Decade
The stock market has taken investors for a wild ride these last few years. When you're investing in stocks for many years, though, even multiple tough market cycles shouldn't deter you from your
Amgen Is Working On a Wegovy Competitor -- What It Means for Investors
It's a race to the riches in the anti-obesity drug market. This therapeutic area is projected to grow exponentially in the coming years. Novo Nordisk is one of the clear market leaders -- for now --
Forget Johnson & Johnson: Buy This Better Healthcare Stock Instead
Many healthcare investors look at Johnson & Johnson (NYSE: JNJ) and see a good, safe dividend stock. But I see an investment that's full of uncertainty and risk.
The company continually runs into
Prediction: These 2 Growth Stocks Could Triple By 2030
Stocks that can triple in six years aren't easy to find. Doing so requires a compound annual growth rate of 20.1%, well above the broader market's historical performance. However, it isn't
Earn $1000 Every Month From These 3 Stocks
When it comes to dividend investing, I am constantly looking for high-quality companies with strong free cash flows that pay safe, reliable, and growing dividends. In today's video, I will show you
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever.
The healthcare industry is a fantastic place to find passive income. Healthcare is recession-proof, and there's always a need for better technology and new treatments. The industry's top dogs have
Why Novavax Stock More Than Doubled Today
Shares of Novavax (NASDAQ: NVAX) are up 12% as of midday Friday following the release of the drugmaker's first-quarter results. It's not the report, however, driving the bulk of today's oversize
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
Cathie Wood can't seem to string together back-to-back years of success. The Ark Invest co-founder and CEO became a rock star among aggressive growth investors in 2020, only to see her
2 Beaten-Down Stocks to Buy and Hold for 10 Years
It's easy to find stocks that are lagging broader equities, even in a bull market like the one we're currently in. It's harder to find beaten-down stocks that still look worth buying and holding
3 Rock-Solid Dividend Stocks That Are Ideal for Retirees
Dividend stocks can be great assets for you in retirement. They can provide you with some recurring income, and they can be relatively safe places to invest your money into for a while. Not all
MacroGenics (MGNX) Q1 2024 Earnings Call Transcript
Image source: The Motley Fool.
MacroGenics (NASDAQ: MGNX)Q1 2024 Earnings CallMay 09, 2024, 4:30 p.m. ET
Operator
Source Fool.com
CorMedix (CRMD) Q1 2024 Earnings Call Transcript
Image source: The Motley Fool.
CorMedix (NASDAQ: CRMD)Q1 2024 Earnings CallMay 09, 2024, 8:30 a.m. ET
Operator
Source Fool.com
2 No-Brainer Dividend Stocks to Buy in May
Dividends may be boring but are essential to building a well-balanced portfolio. After all, dividend payments have accounted for approximately 85% of the S&P 500's total returns since 1960, per a